Symptomtext
This case involves Infant and unknown gender patient who experienced menquadfi was administered to a patient post-excursion with no reported adverse event and temperature excursion due to a power outage and refrigerator malfunction, reports temperature excursion was 0.06c, total time of excursion was 1 hour with no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE lot U7218AC via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious event, "menquadfi was administered to a patient post-excursion with no reported adverse event" (poor quality product administered) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. On an unknown date the patient developed a non-serious temperature excursion due to a power outage and refrigerator malfunction, reports temperature excursion was 0.06c, total time of excursion was 1 hour with no reported adverse event (product storage error) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. It was reported, "MENQUADFI experienced a temperature excursion due to a power outage and refrigerator malfunction; reports temperature excursion was 0.06C; total time of excursion was 1 hour. Pediatrician states MENQUADFI was administered to a patient post-excursion." Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable. It was not reported if the patient received a corrective treatment for the events (MENQUADFI was administered to a patient post-excursion with no reported adverse event, temperature excursion due to a power outage and refrigerator malfunction, reports temperature excursion was 0.06C, total time of excursion was 1 hour with no reported adverse event). At time of reporting, the outcome was Unknown for the event menquadfi was administered to a patient post-excursion with no reported adverse event and was Unknown for the event temperature excursion due to a power outage and refrigerator malfunction, reports temperature excursion was 0.06c, total time of excursion was 1 hour with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.